Author:
Fakhrzad NourolHoda,Barouni Mohsen,Goudarzi Reza,Kojuri Javad,Jahani Yunes,Tasavon Gholamhoseini Mohammad
Abstract
Abstract
Background
Cost-effectiveness analysis plays a key role in evaluating health systems and services. Coronary artery disease is one of the primary health concerns worldwide. This study sought to compare the cost-effectiveness of Coronary Arteries Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) through drug stent using Quality-Adjusted Life Years (QALY) index.
Methods
This is a cohort study involving all patients undergoing CABG and PCI through drug stent in south of Iran. A total of 410 patients were randomly selected to be included in the study. Data were gathered using SF-36, SAQ and a form for cost data from the patients' perspective. The data were analyzed descriptively and inferentially. Considering the analysis of cost-effectiveness, Markov Model was initially developed using TreeAge Pro 2020. Both deterministic and probabilistic sensitivity analyses were performed.
Results
Compared with the group treated with PCI, the total cost of interventions was higher in the CABG group ($102,103.8 vs $71,401.22) and the cost of lost productivity ($20,228.68 vs $7632.11), while the cost of hospitalization was lower in CABG ($67,567.1 vs $49,660.97). The cost of hotel stay and travel ($6967.82 vs $2520.12) and the cost of medication ($7340.18 vs $11,588.01) was lower in CABG. From the patients' perspective and SAQ instrument, CABG was cost-saving, with a reduction of $16,581 for every increase in effectiveness. Based on patients’ perspective and SF-36 instrument, CABG was cost-saving, with a reduction of $34,543 for every increase in effectiveness.
Conclusion
In the same indications, CABG intervention leads to more resource savings.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011;377(9765):529–32. https://doi.org/10.1016/S0140-6736(10)62346-X.
2. Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs. 2011;10(Suppl 2):S5-13. https://doi.org/10.1016/S1474-5151(11)00111-3.
3. Paradis G, Chiolero A. The cardiovascular and chronic diseases epidemic in low- and middle-income countries: a global health challenge. J Am Coll Cardiol. 2011;57:1775–7.
4. Ahmadi AM, Imami Razavi SA, Yaqubi Kalateh Rahman M. Comparison of cost-benefit of transplantation of hemograft heart valves and mechanical heart valves using caliber index in Imam Khomeini Hospital from 2001 to 2006 [M.Sc.]. Tehran: Iran University of Medical Sciences; 2007. [In Persian]
5. Fayyazi P, Sayadi N, Gheibizadeh M. Comparison of quality of life, before and after open heart surgery. Zahedan Med Sci Res. 2011;13(7):1–4.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献